FIELD: medicine.
SUBSTANCE: invention relates to medicine and is intended to reduce the severity of eosinophilic esophagitis. Therapeutic composition comprising an interieukin-4 receptor (IL-4R) inhibitor, such as an anti-IL-4R antibody or an antigen-binding fragment that specifically binds to IL-4P, is administrated to a subject.
EFFECT: method widens the range of therapeutic agents.
17 cl, 4 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR TREATMENT OF ACTIVE EOSINOPHILIC ESOPHAGITIS | 2018 |
|
RU2776651C2 |
| METHODS FOR PREVENTING OR TREATING ALLERGIES BY INTRODUCING AN IL-4R ANTAGONIST | 2017 |
|
RU2777328C2 |
| METHODS FOR TREATING NASAL POLYPOSIS BY ADMINISTERING IL-4R ANTAGONIST | 2014 |
|
RU2674680C2 |
| METHODS FOR THE TREATMENT OF ALLERGY AND INCREASING THE EFFICIENCY OF ALLERGEN-SPECIFIC IMMUNOTHERAPY BY INTRODUCING IL-4R INHIBITOR | 2014 |
|
RU2789047C2 |
| METHODS FOR TREATING ALLERGY AND ENHANCING ALLERGEN-SPECIFIC IMMUNOTHERAPY BY ADMINISTERING IL-4R INHIBITOR | 2014 |
|
RU2679920C2 |
| METHODS OF TREATING OR PREVENTING ASTHMA BY ADMINISTERING IL-4R ANTAGONIST | 2015 |
|
RU2713406C2 |
| METHODS FOR TREATMENT OR PREVENTION OF ASTHMA BY ADMINISTRATION OF IL-4R ANTAGONIST | 2018 |
|
RU2793745C2 |
| METHODS OF TREATING CHRONIC SINUSITIS WITH NASAL POLYPS BY ADMINISTERING IL-4R ANTAGONIST | 2015 |
|
RU2734490C2 |
| METHODS FOR TREATING SEVERE ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR | 2017 |
|
RU2759630C2 |
| METHODS FOR TREATMENT OR PREVENTION OF ASTHMA BY ADMINISTERING IL-4R ANTAGONIST | 2013 |
|
RU2690675C2 |
